RRx-001, a hypoxia-selective epigenetic agent and studied as a radio- and chem-sensitizer, triggers apoptosis and overcomes agent resistance in myeloma. RRx-001 exhibits potent anti-tumor activity with minimal toxicity[1]. RRx-001 is a dual small molecule checkpoint inhibitor by downregulating CD47 and SIRP-alpha[2]. RRx-001 is a potent inhibitor of G6PD and shows potent antimalarial activity[3].
Molekulargewicht:
268.02
Reinheit:
99.79
CAS Nummer:
[925206-65-1]
Formel:
C5H6BrN3O5
Target-Kategorie:
Apoptosis,CD47,Parasite
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten